Drug Target Review2025-09-17T09:00:44
A new experimental stem cell therapy shows promise in repairing brain damage after ischemic strokes – potentially allowing for the development of future treatments that extend the recovery window.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-02-23T14:02:18
Sponsored by bit.bio
2023-03-08T16:29:20
Sponsored by Bio-Techne
2023-04-04T15:03:09
Sponsored by Agilent
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, Drug Target Review
2023-03-20T13:41:33
Sponsored by Bio-Techne
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
Site powered by Webvision Cloud